Selective restriction of ZIKV infection of CD206-expressing M2 macrophages/moDCs results in the attenuation of macrophage–associated inflammatory responses in vivo and prevents the disruption of the Sertoli cell barrier in vitro. The gene discussed is MRC1; the disease is Zika virus infectious disease.